In our lab, we are looking to identify neural crest genes that are important in early craniofacial development. It has previously been shown that both cranial and trunk neural crest cells can give rise to several different cell types. However, only the cranial neural crest cells are capable of differentiation into craniofacial mesenchyme to give rise to bone, muscle and connective tissues. Our hypothesis is that selective gene expression in the early cranial crest allows cranial mesenchymal differentiation To test this hypothesis, we first generated cDNA of chick cranial and trunk neural cell outgrowths from neural tube explants. This was done via the reverse transcriptase PCR reaction in which the RNA is converted into cDNA containing amplimer ends for facilitation of PCR amplification. The cDNA was then screened utilizing specific primers to check for integrity. The cranial cDNA is now being utilized for differential mRNA display screening to identify cranial crest specific genes. We have been able to tentatively identify several cDNAs that are differentially expressed in the cranial crest cells. At this time we are continuing to characterize these genes via in situ hybridization utilizing the cloned cranial crest specific cDNAs. These in situ hybridizations are differential for the cranial neural crest (and the cardiac subdivision of the cranial crest). Corroborating evidence is provided by slot blot analysis. All of the evidence accrued thus far points to a genetic event, as yet, not fully characterized, which is confined to the cranial neural crest. In the future, the goal will be to evaluate the role of these genes in craniofacial development. Fully 75% of all birth defects are found in the craniofacial complex. It is to this and that we will then isolate the mammalian homologue for transgenic mouse studies and human genetic mapping of birth defects involving craniofacial development. The ability to map these and other differentially expressed genes of the cranial neural crest will allow us to understand the control of cranial crest cell differentiation and ultimately, permit us to apply this knowledge to the study of cleft palate and other craniofacial abnormalities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Unknown (K16)
Project #
5K16DE000175-10
Application #
3753474
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Perinpanayagam, H; Schneider, G; Holtman, K et al. (2004) Altered Cbfa1 expression and biomineralization in an osteosarcoma cell line. J Orthop Res 22:404-10
Armstrong, Steven R; Vargas, M A; Chung, I et al. (2004) Resin-dentin interfacial ultrastructure and microtensile dentin bond strength after five-year water storage. Oper Dent 29:705-12
Timmons, Sherry R; Nwankwo, Joseph O; Domann, Frederick E (2002) Acetaldehyde activates Jun/AP-1 expression and DNA binding activity in human oral keratinocytes. Oral Oncol 38:281-90
Armstrong, S R; Keller, J C; Boyer, D B (2001) The influence of water storage and C-factor on the dentin-resin composite microtensile bond strength and debond pathway utilizing a filled and unfilled adhesive resin. Dent Mater 17:268-76
Armstrong, S R; Keller, J C; Boyer, D B (2001) Mode of failure in the dentin-adhesive resin-resin composite bonded joint as determined by strength-based (muTBS) and fracture-based (CNSB) mechanical testing. Dent Mater 17:201-10
Armstrong, S R; Boyer, D B; Keller, J C et al. (1998) Effect of hybrid layer on fracture toughness of adhesively bonded dentin-resin composite joint. Dent Mater 14:91-8
Armstrong, S R; Boyer, D B; Keller, J C (1998) Microtensile bond strength testing and failure analysis of two dentin adhesives. Dent Mater 14:44-50
Kurago, Z B; Lutz, C T; Smith, K D et al. (1998) NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. J Immunol 160:1573-80
Baumgardner, K R; Walton, R E; Osborne, J W et al. (1996) Induced hypoxia in rat pulp and periapex demonstrated by 3H-misonidazole retention. J Dent Res 75:1753-60
Kurago, Z B; Smith, K D; Lutz, C T (1995) NK cell recognition of MHC class I. NK cells are sensitive to peptide-binding groove and surface alpha-helical mutations that affect T cells. J Immunol 154:2631-41

Showing the most recent 10 out of 12 publications